T1	Participants 59 95	ndividual Smith-Lemli-Opitz patients
T2	Participants 168 201	Smith-Lemli-Opitz syndrome (SLOS)
T3	Participants 545 574	23 children (aged 4-17 years)
T4	Participants 1733 1793	individual children with a developmental disability syndrome
